Gain Therapeutics GANX Q2 2025 earnings
Reported August 12, 2025 · Before market open
EPS-$0.19Miss by $0.02
EPS estimate-$0.17
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$33.3K
EPS estimate-$0.14
Versus estimates
Diluted EPS
Ask the moment Gain Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Gain Therapeutics report Q2 2025 earnings?
- Gain Therapeutics (GANX) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Gain Therapeutics's Q2 2025 revenue and EPS?
- Gain Therapeutics reported eps of $-0.19 for Q2 2025.
- Did Gain Therapeutics beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.17 by $0.02.
- How did Gain Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 54.8% from $-0.42.
- Where can I find Gain Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-011220) directly on SEC EDGAR. The filing index links above go to sec.gov.